Exclusive press program selection highlights growing patient access to one-time treatments for sickle cell disease and transfusion-dependent thalassemia.
Somerville, Massachusetts, 4 December 2025 – Genetix...
The move strengthens AstraZeneca’s global market presence, giving the pharma giant greater access to U.S. investors and deeper capital resources.
LONDON — November 3, 2025....
The merger brings together two trusted giants—Kimberly-Clark and Kenvue to redefine the future of personal care and consumer health worldwide
DALLAS — November 3, 2025....
Empowering communities across the U.S. with equal access to life-saving heart health services
RAHWAY, N.J. — November 4, 2025. Heart disease remains the leading cause...
The tech-driven insurer brings $0 virtual care, personalized AI tools, and the first menopause health plan to North Texas residents.
DALLAS — November 3, 2025....
